speb/financial-data huggingface dataset:
CNXN cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 58086000.00
CNXN cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -1084000.00
CNXN cash_flow (quarterly, 2026-03-31) — Change In Inventory: -50727000.00
CNXN cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 574000.00
CNXN cash_flow (quarterly, 2026-03-31) — Change In Payable: 58086000.00
CNXN cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 57002000.00
CNXN cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -775000.00
CNXN cash_flow (quarterly, 2026-03-31) — Change In Receivables: -13700000.00
CNXN cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -7626000.00
CNXN cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -13700000.00
CNXN cash_flow (quarterly, 2026-03-31) — Changes In Cash: 3038000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Common Stock: 296000.00
CNXN cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -5040000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 921692000.00
CNXN cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -2481000.00
CNXN income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 589129000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 80724000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Current Assets: 1290605000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 477205000.00
CNXN cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -166000.00
CNXN cash_flow (quarterly, 2026-03-31) — Deferred Tax: -166000.00
CNXN cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 2797000.00
CNXN income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 2800000.00
CNXN cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 2797000.00
CNXN income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 2800000.00
CNXN income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 25281000.00
CNXN income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.68
CNXN income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 17223000.00
CNXN income_statement (quarterly, 2026-03-31) — EBIT: 24637000.00
CNXN income_statement (quarterly, 2026-03-31) — EBITDA: 27437000.00
CNXN cash_flow (quarterly, 2026-03-31) — End Cash Position: 196259000.00
CNXN cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -8192000.00
CNXN cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 12283000.00
CNXN cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 50000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -88000.00
CNXN income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 97200000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Goodwill: 73602000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 74286000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Gross PPE: 53720000.00
CNXN income_statement (quarterly, 2026-03-31) — Gross Profit: 132737000.00
CNXN income_statement (quarterly, 2026-03-31) — Interest Income: 3363000.00
CNXN income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 3363000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Inventory: 194294000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Invested Capital: 921692000.00
CNXN cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -3037000.00
CNXN cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 0.00
CNXN balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 6426000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 6426000.00
CNXN cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -2481000.00
CNXN income_statement (quarterly, 2026-03-31) — Net Income: 17223000.00
CNXN income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 17223000.00
CNXN income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 17223000.00
CNXN income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 17223000.00
CNXN income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 17223000.00
CNXN cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 17223000.00
CNXN income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 17223000.00
CNXN income_statement (quarterly, 2026-03-31) — Net Interest Income: 1963000.00
CNXN cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -1053000.00
CNXN cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 0.00
CNXN income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 1963000.00
CNXN cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -671000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Net PPE: 53720000.00
CNXN cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -1984000.00
CNXN cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 0.00
CNXN balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 847406000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 19695000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 19695000.00
CNXN income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 30497000.00
CNXN income_statement (quarterly, 2026-03-31) — Normalized Income: 19456800.00
CNXN cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 14267000.00
CNXN cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 50000.00
CNXN income_statement (quarterly, 2026-03-31) — Operating Income: 24637000.00
CNXN income_statement (quarterly, 2026-03-31) — Operating Revenue: 721866000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 25220000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 23382000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -88000.00
CNXN income_statement (quarterly, 2026-03-31) — Other Gand A: 12700000.00
CNXN income_statement (quarterly, 2026-03-31) — Other Income Expense: -3060000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 684000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 6407000.00
CNXN income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 2000000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Other Properties: 53720000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 215189000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Payables: 396481000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 477205000.00
CNXN income_statement (quarterly, 2026-03-31) — Pretax Income: 23588000.00
CNXN cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 239000.00
CNXN cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -54270000.00
CNXN cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -1984000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Receivables: 661481000.00
CNXN income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 589132000.00
CNXN income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 2797000.00
CNXN cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: 0.00
CNXN cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -2481000.00
CNXN income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 3060000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 918073000.00
CNXN income_statement (quarterly, 2026-03-31) — Salaries And Wages: 84500000.00
CNXN cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 53217000.00
CNXN income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 6100000.00
CNXN income_statement (quarterly, 2026-03-31) — Selling General And Administration: 103300000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Share Issued: 29566000.00
CNXN cash_flow (quarterly, 2026-03-31) — Short Term Debt Issuance: 0.00
CNXN cash_flow (quarterly, 2026-03-31) — Short Term Debt Payments: 0.00
CNXN income_statement (quarterly, 2026-03-31) — Special Income Charges: -3060000.00
CNXN cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 2639000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 921692000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 847406000.00
CNXN income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -826200.00
CNXN income_statement (quarterly, 2026-03-31) — Tax Provision: 6365000.00
CNXN income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.27
CNXN balance_sheet (quarterly, 2026-03-31) — Total Assets: 1425018000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 921692000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Total Debt: 6426000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 921692000.00
CNXN income_statement (quarterly, 2026-03-31) — Total Expenses: 697229000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 503326000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 134413000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 26121000.00
CNXN income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 20225000.00
CNXN income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 1400000.00
CNXN income_statement (quarterly, 2026-03-31) — Total Unusual Items: -3060000.00
CNXN income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -3060000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 4346000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 143164000.00
CNXN balance_sheet (quarterly, 2026-03-31) — Working Capital: 813400000.00
CNXU income_statement (annual, 2024-10-31) — +Operating Expense: 643042.00
CNXU income_statement (annual, 2024-10-31) — +Total Revenue: 0.00
CNXU balance_sheet (annual, 2024-10-31) — Accounts Payable: 319024.00
CNXU balance_sheet (annual, 2024-10-31) — Accumulated Depreciation: 0.00
CNXU balance_sheet (annual, 2024-10-31) — Additional Paid In Capital: 684399.00
CNXU income_statement (annual, 2024-10-31) — Amortization: 0.00
CNXU cash_flow (annual, 2024-10-31) — Amortization Cash Flow: 0.00
CNXU cash_flow (annual, 2024-10-31) — Amortization Of Intangibles: 0.00
CNXU income_statement (annual, 2024-10-31) — Amortization Of Intangibles Income Statement: 0.00
CNXU income_statement (annual, 2024-10-31) — Basic Average Shares: 20916173.00
CNXU income_statement (annual, 2024-10-31) — Basic EPS: -0.02
CNXU cash_flow (annual, 2024-10-31) — Beginning Cash Position: 0.00
CNXU balance_sheet (annual, 2024-10-31) — Capital Stock: 8528.00
CNXU balance_sheet (annual, 2024-10-31) — Cash And Cash Equivalents: 314616.00
CNXU balance_sheet (annual, 2024-10-31) — Cash Cash Equivalents And Short Term Investments: 314616.00
CNXU cash_flow (annual, 2024-10-31) — Cash Flow From Continuing Financing Activities: 534637.00
CNXU cash_flow (annual, 2024-10-31) — Cash Flow From Continuing Investing Activities: 0.00
CNXU cash_flow (annual, 2024-10-31) — Cash Flow From Continuing Operating Activities: -225439.00
CNXU cash_flow (annual, 2024-10-31) — Change In Account Payable: 452017.00
CNXU cash_flow (annual, 2024-10-31) — Change In Payable: 452017.00
CNXU cash_flow (annual, 2024-10-31) — Change In Payables And Accrued Expense: 452017.00
CNXU cash_flow (annual, 2024-10-31) — Change In Prepaid Assets: -29446.00
CNXU cash_flow (annual, 2024-10-31) — Change In Receivables: 0.00
CNXU cash_flow (annual, 2024-10-31) — Change In Working Capital: 422571.00
CNXU cash_flow (annual, 2024-10-31) — Changes In Cash: 309198.00
CNXU balance_sheet (annual, 2024-10-31) — Common Stock: 8528.00
CNXU balance_sheet (annual, 2024-10-31) — Common Stock Equity: 94964.00
CNXU cash_flow (annual, 2024-10-31) — Common Stock Issuance: 531000.00
CNXU balance_sheet (annual, 2024-10-31) — Current Accrued Expenses: 13923.00
CNXU balance_sheet (annual, 2024-10-31) — Current Assets: 347237.00
CNXU balance_sheet (annual, 2024-10-31) — Current Liabilities: 340859.00
CNXU cash_flow (annual, 2024-10-31) — Depreciation: 0.00
CNXU cash_flow (annual, 2024-10-31) — Depreciation Amortization Depletion: 0.00
CNXU income_statement (annual, 2024-10-31) — Depreciation Amortization Depletion Income Statement: 0.00
CNXU cash_flow (annual, 2024-10-31) — Depreciation And Amortization: 0.00
CNXU income_statement (annual, 2024-10-31) — Depreciation And Amortization In Income Statement: 0.00
CNXU income_statement (annual, 2024-10-31) — Depreciation Income Statement: 0.00
CNXU income_statement (annual, 2024-10-31) — Diluted Average Shares: 20916173.00
CNXU income_statement (annual, 2024-10-31) — Diluted EPS: -0.02
CNXU income_statement (annual, 2024-10-31) — Diluted NI Availto Com Stockholders: -471867.00
CNXU balance_sheet (annual, 2024-10-31) — Dueto Related Parties Current: 7912.00
CNXU income_statement (annual, 2024-10-31) — EBIT: -455362.00
CNXU income_statement (annual, 2024-10-31) — EBITDA: -455362.00
CNXU cash_flow (annual, 2024-10-31) — Effect Of Exchange Rate Changes: 5418.00
CNXU cash_flow (annual, 2024-10-31) — End Cash Position: 314616.00
CNXU cash_flow (annual, 2024-10-31) — Financing Cash Flow: 534637.00
CNXU cash_flow (annual, 2024-10-31) — Free Cash Flow: -225439.00
CNXU income_statement (annual, 2024-10-31) — Gain On Sale Of Security: 5370.00
CNXU income_statement (annual, 2024-10-31) — General And Administrative Expense: 352500.00
CNXU balance_sheet (annual, 2024-10-31) — Goodwill And Other Intangible Assets: 186703.00
CNXU balance_sheet (annual, 2024-10-31) — Gross PPE: 0.00
CNXU cash_flow (annual, 2024-10-31) — Income Tax Paid Supplemental Data: 0.00
CNXU income_statement (annual, 2024-10-31) — Insurance And Claims: 0.00
CNXU income_statement (annual, 2024-10-31) — Interest Expense: 16505.00
CNXU income_statement (annual, 2024-10-31) — Interest Expense Non Operating: 16505.00
CNXU income_statement (annual, 2024-10-31) — Interest Income: 0.00
CNXU income_statement (annual, 2024-10-31) — Interest Income Non Operating: 0.00
CNXU cash_flow (annual, 2024-10-31) — Interest Paid Supplemental Data: 0.00
CNXU balance_sheet (annual, 2024-10-31) — Interest Payable: 13923.00
CNXU balance_sheet (annual, 2024-10-31) — Invested Capital: 193081.00
CNXU cash_flow (annual, 2024-10-31) — Investing Cash Flow: 0.00
CNXU cash_flow (annual, 2024-10-31) — Issuance Of Capital Stock: 531000.00
CNXU balance_sheet (annual, 2024-10-31) — Long Term Debt: 98117.00
CNXU balance_sheet (annual, 2024-10-31) — Long Term Debt And Capital Lease Obligation: 98117.00
CNXU cash_flow (annual, 2024-10-31) — Long Term Debt Payments: 0.00
CNXU balance_sheet (annual, 2024-10-31) — Machinery Furniture Equipment: 0.00
CNXU cash_flow (annual, 2024-10-31) — Net Common Stock Issuance: 531000.00
CNXU income_statement (annual, 2024-10-31) — Net Income: -471867.00
CNXU income_statement (annual, 2024-10-31) — Net Income Common Stockholders: -471867.00
CNXU income_statement (annual, 2024-10-31) — Net Income Continuous Operations: -471867.00
CNXU income_statement (annual, 2024-10-31) — Net Income From Continuing And Discontinued Operation: -471867.00
CNXU income_statement (annual, 2024-10-31) — Net Income From Continuing Operation Net Minority Interest: -471867.00
CNXU cash_flow (annual, 2024-10-31) — Net Income From Continuing Operations: -471867.00
CNXU income_statement (annual, 2024-10-31) — Net Income Including Noncontrolling Interests: -471867.00
CNXU income_statement (annual, 2024-10-31) — Net Interest Income: -17346.00
CNXU cash_flow (annual, 2024-10-31) — Net Issuance Payments Of Debt: 0.00
CNXU cash_flow (annual, 2024-10-31) — Net Long Term Debt Issuance: 0.00
CNXU income_statement (annual, 2024-10-31) — Net Non Operating Interest Income Expense: -17346.00
CNXU cash_flow (annual, 2024-10-31) — Net Other Financing Charges: 3637.00
CNXU balance_sheet (annual, 2024-10-31) — Net PPE: 0.00
CNXU cash_flow (annual, 2024-10-31) — Net PPE Purchase And Sale: 0.00
CNXU balance_sheet (annual, 2024-10-31) — Net Tangible Assets: -91739.00
CNXU balance_sheet (annual, 2024-10-31) — Non Current Deferred Assets: 0.00
CNXU income_statement (annual, 2024-10-31) — Normalized EBITDA: -425500.00
CNXU income_statement (annual, 2024-10-31) — Normalized Income: -442005.00
CNXU balance_sheet (annual, 2024-10-31) — Notes Receivable: 0.00
CNXU cash_flow (annual, 2024-10-31) — Operating Cash Flow: -225439.00
CNXU cash_flow (annual, 2024-10-31) — Operating Gains Losses: 35232.00
CNXU income_statement (annual, 2024-10-31) — Operating Income: -643042.00
CNXU income_statement (annual, 2024-10-31) — Operating Revenue: 0.00
CNXU balance_sheet (annual, 2024-10-31) — Ordinary Shares Number: 20916173.00
CNXU income_statement (annual, 2024-10-31) — Other Gand A: 78642.00
CNXU income_statement (annual, 2024-10-31) — Other Income Expense: 188521.00
CNXU balance_sheet (annual, 2024-10-31) — Other Intangible Assets: 186703.00
CNXU cash_flow (annual, 2024-10-31) — Other Non Cash Items: -218182.00
CNXU income_statement (annual, 2024-10-31) — Other Non Operating Income Expenses: 218383.00
CNXU income_statement (annual, 2024-10-31) — Other Operating Expenses: 42352.00
CNXU income_statement (annual, 2024-10-31) — Other Special Charges: 35232.00
CNXU balance_sheet (annual, 2024-10-31) — Payables: 326936.00
CNXU balance_sheet (annual, 2024-10-31) — Payables And Accrued Expenses: 340859.00
CNXU balance_sheet (annual, 2024-10-31) — Preferred Stock: 0.00
CNXU balance_sheet (annual, 2024-10-31) — Prepaid Assets: 32621.00
CNXU income_statement (annual, 2024-10-31) — Pretax Income: -471867.00
CNXU cash_flow (annual, 2024-10-31) — Purchase Of PPE: 0.00
CNXU balance_sheet (annual, 2024-10-31) — Receivables: 0.00
CNXU income_statement (annual, 2024-10-31) — Reconciled Depreciation: 0.00
CNXU cash_flow (annual, 2024-10-31) — Repayment Of Debt: 0.00
CNXU income_statement (annual, 2024-10-31) — Research And Development: 280081.00
CNXU balance_sheet (annual, 2024-10-31) — Restricted Cash: 0.00
CNXU balance_sheet (annual, 2024-10-31) — Retained Earnings: -597963.00
CNXU income_statement (annual, 2024-10-31) — Salaries And Wages: 273858.00
CNXU income_statement (annual, 2024-10-31) — Selling And Marketing Expense: 10461.00
CNXU income_statement (annual, 2024-10-31) — Selling General And Administration: 362961.00
CNXU balance_sheet (annual, 2024-10-31) — Share Issued: 20916173.00
CNXU income_statement (annual, 2024-10-31) — Special Income Charges: -35232.00
CNXU cash_flow (annual, 2024-10-31) — Stock Based Compensation: 6807.00
CNXU balance_sheet (annual, 2024-10-31) — Stockholders Equity: 94964.00
CNXU balance_sheet (annual, 2024-10-31) — Tangible Book Value: -91739.00
CNXU income_statement (annual, 2024-10-31) — Tax Effect Of Unusual Items: 0.00
CNXU income_statement (annual, 2024-10-31) — Tax Provision: 0.00
CNXU income_statement (annual, 2024-10-31) — Tax Rate For Calcs: 0.00
CNXU balance_sheet (annual, 2024-10-31) — Taxes Receivable: 0.00
CNXU balance_sheet (annual, 2024-10-31) — Total Assets: 533940.00
CNXU balance_sheet (annual, 2024-10-31) — Total Capitalization: 193081.00
CNXU balance_sheet (annual, 2024-10-31) — Total Debt: 98117.00
CNXU balance_sheet (annual, 2024-10-31) — Total Equity Gross Minority Interest: 94964.00
CNXU income_statement (annual, 2024-10-31) — Total Expenses: 643042.00
CNXU balance_sheet (annual, 2024-10-31) — Total Liabilities Net Minority Interest: 438976.00
CNXU balance_sheet (annual, 2024-10-31) — Total Non Current Assets: 186703.00
CNXU balance_sheet (annual, 2024-10-31) — Total Non Current Liabilities Net Minority Interest: 98117.00
CNXU income_statement (annual, 2024-10-31) — Total Operating Income As Reported: -643883.00
CNXU income_statement (annual, 2024-10-31) — Total Other Finance Cost: 841.00
CNXU income_statement (annual, 2024-10-31) — Total Unusual Items: -29862.00
CNXU income_statement (annual, 2024-10-31) — Total Unusual Items Excluding Goodwill: -29862.00
CNXU balance_sheet (annual, 2024-10-31) — Working Capital: 6378.00
CNXU income_statement (quarterly, 2025-01-31) — +Operating Expense: 332721.00
CNXU income_statement (quarterly, 2025-01-31) — +Total Revenue: 0.00
CNXU income_statement (quarterly, 2025-01-31) — Amortization: 0.00
CNXU cash_flow (quarterly, 2025-01-31) — Amortization Cash Flow: 0.00
CNXU cash_flow (quarterly, 2025-01-31) — Amortization Of Intangibles: 0.00
CNXU income_statement (quarterly, 2025-01-31) — Amortization Of Intangibles Income Statement: 0.00
CNXU income_statement (quarterly, 2025-01-31) — Basic Average Shares: 20916173.00
CNXU income_statement (quarterly, 2025-01-31) — Basic EPS: -0.01
CNXU cash_flow (quarterly, 2025-01-31) — Beginning Cash Position: 314616.00
CNXU cash_flow (quarterly, 2025-01-31) — Capital Expenditure: -13508.00
CNXU cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Financing Activities: 550000.00
CNXU cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Investing Activities: -13508.00
CNXU cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Operating Activities: -235853.00
CNXU cash_flow (quarterly, 2025-01-31) — Change In Account Payable: 42811.00
CNXU cash_flow (quarterly, 2025-01-31) — Change In Other Current Liabilities: 0.00
CNXU cash_flow (quarterly, 2025-01-31) — Change In Payable: 42811.00
CNXU cash_flow (quarterly, 2025-01-31) — Change In Payables And Accrued Expense: 42811.00
CNXU cash_flow (quarterly, 2025-01-31) — Change In Prepaid Assets: -33412.00
CNXU cash_flow (quarterly, 2025-01-31) — Change In Receivables: -5261.00
CNXU cash_flow (quarterly, 2025-01-31) — Change In Working Capital: 4138.00
CNXU cash_flow (quarterly, 2025-01-31) — Changes In Cash: 300639.00
CNXU cash_flow (quarterly, 2025-01-31) — Common Stock Issuance: 550000.00
CNXU cash_flow (quarterly, 2025-01-31) — Depreciation: 563.00
CNXU cash_flow (quarterly, 2025-01-31) — Depreciation Amortization Depletion: 563.00
CNXU income_statement (quarterly, 2025-01-31) — Depreciation Amortization Depletion Income Statement: 563.00
CNXU cash_flow (quarterly, 2025-01-31) — Depreciation And Amortization: 563.00
CNXU income_statement (quarterly, 2025-01-31) — Depreciation And Amortization In Income Statement: 563.00
CNXU income_statement (quarterly, 2025-01-31) — Depreciation Income Statement: 563.00
CNXU income_statement (quarterly, 2025-01-31) — Diluted Average Shares: 20916173.00
CNXU income_statement (quarterly, 2025-01-31) — Diluted EPS: -0.01
CNXU income_statement (quarterly, 2025-01-31) — Diluted NI Availto Com Stockholders: -290064.00
CNXU income_statement (quarterly, 2025-01-31) — EBIT: -286454.00
CNXU income_statement (quarterly, 2025-01-31) — EBITDA: -285891.00
CNXU cash_flow (quarterly, 2025-01-31) — Effect Of Exchange Rate Changes: -2982.00
CNXU cash_flow (quarterly, 2025-01-31) — End Cash Position: 612273.00
CNXU cash_flow (quarterly, 2025-01-31) — Financing Cash Flow: 550000.00
CNXU cash_flow (quarterly, 2025-01-31) — Free Cash Flow: -249361.00
CNXU cash_flow (quarterly, 2025-01-31) — Gain Loss On Sale Of PPE: 0.00
CNXU income_statement (quarterly, 2025-01-31) — Gain On Sale Of Security: 3823.00
CNXU income_statement (quarterly, 2025-01-31) — General And Administrative Expense: 262716.00
CNXU cash_flow (quarterly, 2025-01-31) — Income Tax Paid Supplemental Data: 0.00
CNXU income_statement (quarterly, 2025-01-31) — Insurance And Claims: 0.00
CNXU income_statement (quarterly, 2025-01-31) — Interest Expense: 3610.00
CNXU income_statement (quarterly, 2025-01-31) — Interest Expense Non Operating: 3610.00
CNXU income_statement (quarterly, 2025-01-31) — Interest Income: 0.00
CNXU income_statement (quarterly, 2025-01-31) — Interest Income Non Operating: 0.00
CNXU cash_flow (quarterly, 2025-01-31) — Interest Paid Supplemental Data: 0.00
CNXU cash_flow (quarterly, 2025-01-31) — Investing Cash Flow: -13508.00
CNXU cash_flow (quarterly, 2025-01-31) — Issuance Of Capital Stock: 550000.00
CNXU cash_flow (quarterly, 2025-01-31) — Net Common Stock Issuance: 550000.00
CNXU income_statement (quarterly, 2025-01-31) — Net Income: -290064.00
CNXU income_statement (quarterly, 2025-01-31) — Net Income Common Stockholders: -290064.00
CNXU income_statement (quarterly, 2025-01-31) — Net Income Continuous Operations: -290064.00
CNXU income_statement (quarterly, 2025-01-31) — Net Income From Continuing And Discontinued Operation: -290064.00
CNXU income_statement (quarterly, 2025-01-31) — Net Income From Continuing Operation Net Minority Interest: -290064.00
CNXU cash_flow (quarterly, 2025-01-31) — Net Income From Continuing Operations: -290064.00
CNXU income_statement (quarterly, 2025-01-31) — Net Income Including Noncontrolling Interests: -290064.00
CNXU income_statement (quarterly, 2025-01-31) — Net Interest Income: -4342.00
CNXU income_statement (quarterly, 2025-01-31) — Net Non Operating Interest Income Expense: -4342.00
CNXU cash_flow (quarterly, 2025-01-31) — Net PPE Purchase And Sale: -13508.00
CNXU income_statement (quarterly, 2025-01-31) — Normalized EBITDA: -289714.00
CNXU income_statement (quarterly, 2025-01-31) — Normalized Income: -293887.00
CNXU cash_flow (quarterly, 2025-01-31) — Operating Cash Flow: -235853.00
CNXU income_statement (quarterly, 2025-01-31) — Operating Income: -332721.00
CNXU income_statement (quarterly, 2025-01-31) — Operating Revenue: 0.00
CNXU income_statement (quarterly, 2025-01-31) — Other Gand A: 53030.00
CNXU income_statement (quarterly, 2025-01-31) — Other Income Expense: 46999.00
CNXU cash_flow (quarterly, 2025-01-31) — Other Non Cash Items: -16490.00
CNXU income_statement (quarterly, 2025-01-31) — Other Non Operating Income Expenses: 43176.00
CNXU income_statement (quarterly, 2025-01-31) — Other Operating Expenses: 37883.00
CNXU income_statement (quarterly, 2025-01-31) — Pretax Income: -290064.00
CNXU cash_flow (quarterly, 2025-01-31) — Proceeds From Stock Option Exercised: 0.00
CNXU cash_flow (quarterly, 2025-01-31) — Purchase Of PPE: -13508.00
CNXU income_statement (quarterly, 2025-01-31) — Reconciled Depreciation: 563.00
CNXU income_statement (quarterly, 2025-01-31) — Research And Development: 61550.00
CNXU income_statement (quarterly, 2025-01-31) — Salaries And Wages: 209686.00
CNXU income_statement (quarterly, 2025-01-31) — Selling And Marketing Expense: 7892.00
CNXU income_statement (quarterly, 2025-01-31) — Selling General And Administration: 270608.00
CNXU cash_flow (quarterly, 2025-01-31) — Stock Based Compensation: 66000.00
CNXU income_statement (quarterly, 2025-01-31) — Tax Effect Of Unusual Items: 0.00
CNXU income_statement (quarterly, 2025-01-31) — Tax Provision: 0.00
CNXU income_statement (quarterly, 2025-01-31) — Tax Rate For Calcs: 0.00
CNXU income_statement (quarterly, 2025-01-31) — Total Expenses: 332721.00
CNXU income_statement (quarterly, 2025-01-31) — Total Operating Income As Reported: -333453.00
CNXU income_statement (quarterly, 2025-01-31) — Total Other Finance Cost: 732.00
CNXU income_statement (quarterly, 2025-01-31) — Total Unusual Items: 3823.00
CNXU income_statement (quarterly, 2025-01-31) — Total Unusual Items Excluding Goodwill: 3823.00
CNXU income_statement (quarterly, 2025-04-30) — +Operating Expense: 456055.00
CNXU income_statement (quarterly, 2025-04-30) — +Total Revenue: 0.00
CNXU cash_flow (quarterly, 2025-04-30) — Amortization Cash Flow: 1133.00
CNXU cash_flow (quarterly, 2025-04-30) — Amortization Of Intangibles: 1133.00
CNXU income_statement (quarterly, 2025-04-30) — Basic Average Shares: 20916173.00
CNXU income_statement (quarterly, 2025-04-30) — Basic EPS: -0.02
CNXU cash_flow (quarterly, 2025-04-30) — Beginning Cash Position: 612273.00
CNXU cash_flow (quarterly, 2025-04-30) — Capital Expenditure: -4760.00
CNXU cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Financing Activities: -102307.00
CNXU cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Investing Activities: -4760.00
CNXU cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Operating Activities: -428752.00
CNXU cash_flow (quarterly, 2025-04-30) — Change In Account Payable: 68612.00
CNXU cash_flow (quarterly, 2025-04-30) — Change In Other Current Liabilities: 66000.00
CNXU cash_flow (quarterly, 2025-04-30) — Change In Payable: 68612.00
CNXU cash_flow (quarterly, 2025-04-30) — Change In Payables And Accrued Expense: 68612.00
CNXU cash_flow (quarterly, 2025-04-30) — Change In Prepaid Assets: -100325.00
CNXU cash_flow (quarterly, 2025-04-30) — Change In Receivables: -6701.00
CNXU cash_flow (quarterly, 2025-04-30) — Change In Working Capital: 27586.00
CNXU cash_flow (quarterly, 2025-04-30) — Changes In Cash: -535819.00
CNXU cash_flow (quarterly, 2025-04-30) — Common Stock Issuance: 0.00
CNXU cash_flow (quarterly, 2025-04-30) — Depreciation: 2268.00
CNXU cash_flow (quarterly, 2025-04-30) — Depreciation Amortization Depletion: 3401.00
CNXU income_statement (quarterly, 2025-04-30) — Depreciation Amortization Depletion Income Statement: 3401.00
CNXU cash_flow (quarterly, 2025-04-30) — Depreciation And Amortization: 3401.00
CNXU income_statement (quarterly, 2025-04-30) — Depreciation And Amortization In Income Statement: 3401.00
CNXU income_statement (quarterly, 2025-04-30) — Diluted Average Shares: 20916173.00
CNXU income_statement (quarterly, 2025-04-30) — Diluted EPS: -0.02
CNXU income_statement (quarterly, 2025-04-30) — Diluted NI Availto Com Stockholders: -458050.00
CNXU income_statement (quarterly, 2025-04-30) — EBIT: -456667.00
CNXU income_statement (quarterly, 2025-04-30) — EBITDA: -453266.00
CNXU cash_flow (quarterly, 2025-04-30) — End Cash Position: 79436.00
CNXU cash_flow (quarterly, 2025-04-30) — Financing Cash Flow: -102307.00
CNXU cash_flow (quarterly, 2025-04-30) — Free Cash Flow: -433512.00
CNXU cash_flow (quarterly, 2025-04-30) — Gain Loss On Sale Of PPE: 0.00
CNXU income_statement (quarterly, 2025-04-30) — Gain On Sale Of Security: 314.00
CNXU income_statement (quarterly, 2025-04-30) — General And Administrative Expense: 334379.00
CNXU cash_flow (quarterly, 2025-04-30) — Income Tax Paid Supplemental Data: 0.00
CNXU income_statement (quarterly, 2025-04-30) — Insurance And Claims: 0.00
CNXU income_statement (quarterly, 2025-04-30) — Interest Expense: 1383.00
CNXU income_statement (quarterly, 2025-04-30) — Interest Expense Non Operating: 1383.00
CNXU income_statement (quarterly, 2025-04-30) — Interest Income: 0.00
CNXU income_statement (quarterly, 2025-04-30) — Interest Income Non Operating: 0.00
CNXU cash_flow (quarterly, 2025-04-30) — Interest Paid Supplemental Data: 18916.00
CNXU cash_flow (quarterly, 2025-04-30) — Investing Cash Flow: -4760.00
CNXU cash_flow (quarterly, 2025-04-30) — Issuance Of Capital Stock: 0.00
CNXU cash_flow (quarterly, 2025-04-30) — Net Common Stock Issuance: 0.00
CNXU income_statement (quarterly, 2025-04-30) — Net Income: -458050.00
CNXU income_statement (quarterly, 2025-04-30) — Net Income Common Stockholders: -458050.00
CNXU income_statement (quarterly, 2025-04-30) — Net Income Continuous Operations: -458050.00
CNXU income_statement (quarterly, 2025-04-30) — Net Income From Continuing And Discontinued Operation: -458050.00
CNXU income_statement (quarterly, 2025-04-30) — Net Income From Continuing Operation Net Minority Interest: -458050.00
CNXU cash_flow (quarterly, 2025-04-30) — Net Income From Continuing Operations: -458050.00
CNXU income_statement (quarterly, 2025-04-30) — Net Income Including Noncontrolling Interests: -458050.00
CNXU income_statement (quarterly, 2025-04-30) — Net Interest Income: -2309.00
CNXU income_statement (quarterly, 2025-04-30) — Net Non Operating Interest Income Expense: -2309.00
CNXU cash_flow (quarterly, 2025-04-30) — Net PPE Purchase And Sale: -4760.00
CNXU income_statement (quarterly, 2025-04-30) — Normalized EBITDA: -453580.00
CNXU income_statement (quarterly, 2025-04-30) — Normalized Income: -458364.00
CNXU cash_flow (quarterly, 2025-04-30) — Operating Cash Flow: -428752.00
CNXU income_statement (quarterly, 2025-04-30) — Operating Income: -456055.00
CNXU income_statement (quarterly, 2025-04-30) — Operating Revenue: 0.00
CNXU income_statement (quarterly, 2025-04-30) — Other Gand A: 251263.00
CNXU income_statement (quarterly, 2025-04-30) — Other Income Expense: 314.00
CNXU cash_flow (quarterly, 2025-04-30) — Other Non Cash Items: 64311.00
CNXU income_statement (quarterly, 2025-04-30) — Other Operating Expenses: 150.00
CNXU income_statement (quarterly, 2025-04-30) — Pretax Income: -458050.00
CNXU cash_flow (quarterly, 2025-04-30) — Proceeds From Stock Option Exercised: 0.00
CNXU cash_flow (quarterly, 2025-04-30) — Purchase Of PPE: -4760.00
CNXU income_statement (quarterly, 2025-04-30) — Reconciled Depreciation: 3401.00
CNXU income_statement (quarterly, 2025-04-30) — Research And Development: 98802.00
CNXU income_statement (quarterly, 2025-04-30) — Salaries And Wages: 83116.00
CNXU income_statement (quarterly, 2025-04-30) — Selling And Marketing Expense: 19323.00
CNXU income_statement (quarterly, 2025-04-30) — Selling General And Administration: 353702.00
CNXU income_statement (quarterly, 2025-04-30) — Tax Effect Of Unusual Items: 0.00
CNXU income_statement (quarterly, 2025-04-30) — Tax Provision: 0.00
CNXU income_statement (quarterly, 2025-04-30) — Tax Rate For Calcs: 0.00
CNXU income_statement (quarterly, 2025-04-30) — Total Expenses: 456055.00
CNXU income_statement (quarterly, 2025-04-30) — Total Operating Income As Reported: -456981.00
CNXU income_statement (quarterly, 2025-04-30) — Total Other Finance Cost: 926.00
CNXU income_statement (quarterly, 2025-04-30) — Total Unusual Items: 314.00
CNXU income_statement (quarterly, 2025-04-30) — Total Unusual Items Excluding Goodwill: 314.00
CNXU income_statement (annual, 2025-10-31) — +Operating Expense: 3958329.00
CNXU income_statement (annual, 2025-10-31) — +Total Revenue: 0.00
CNXU balance_sheet (annual, 2025-10-31) — Accounts Payable: 256296.00
CNXU balance_sheet (annual, 2025-10-31) — Accumulated Depreciation: -7431.00
CNXU balance_sheet (annual, 2025-10-31) — Additional Paid In Capital: 11855307.00
CNXU income_statement (annual, 2025-10-31) — Amortization: 9819.00
CNXU cash_flow (annual, 2025-10-31) — Amortization Cash Flow: 9819.00
CNXU cash_flow (annual, 2025-10-31) — Amortization Of Intangibles: 9819.00
CNXU income_statement (annual, 2025-10-31) — Amortization Of Intangibles Income Statement: 9819.00
CNXU income_statement (annual, 2025-10-31) — Basic Average Shares: 20916173.00
CNXU income_statement (annual, 2025-10-31) — Basic EPS: -0.19
CNXU cash_flow (annual, 2025-10-31) — Beginning Cash Position: 314616.00
CNXU cash_flow (annual, 2025-10-31) — Capital Expenditure: -18668.00
CNXU balance_sheet (annual, 2025-10-31) — Capital Stock: 18906.00
CNXU balance_sheet (annual, 2025-10-31) — Cash And Cash Equivalents: 4808965.00
CNXU balance_sheet (annual, 2025-10-31) — Cash Cash Equivalents And Short Term Investments: 4808965.00
CNXU balance_sheet (annual, 2025-10-31) — Cash Financial: 4808965.00
CNXU cash_flow (annual, 2025-10-31) — Cash Flow From Continuing Financing Activities: 6283384.00
CNXU cash_flow (annual, 2025-10-31) — Cash Flow From Continuing Investing Activities: -89994.00
CNXU cash_flow (annual, 2025-10-31) — Cash Flow From Continuing Operating Activities: -1669975.00
CNXU cash_flow (annual, 2025-10-31) — Change In Account Payable: 89423.00
CNXU cash_flow (annual, 2025-10-31) — Change In Payable: 165423.00
CNXU cash_flow (annual, 2025-10-31) — Change In Payables And Accrued Expense: 165423.00
CNXU cash_flow (annual, 2025-10-31) — Change In Prepaid Assets: -64798.00
CNXU cash_flow (annual, 2025-10-31) — Change In Receivables: -3037.00
CNXU cash_flow (annual, 2025-10-31) — Change In Working Capital: 97588.00
CNXU cash_flow (annual, 2025-10-31) — Changes In Cash: 4523415.00
CNXU balance_sheet (annual, 2025-10-31) — Common Stock: 18906.00
CNXU balance_sheet (annual, 2025-10-31) — Common Stock Equity: 7352693.00
CNXU cash_flow (annual, 2025-10-31) — Common Stock Issuance: 6423957.00
CNXU balance_sheet (annual, 2025-10-31) — Current Accrued Expenses: 0.00
CNXU balance_sheet (annual, 2025-10-31) — Current Assets: 7458413.00
CNXU balance_sheet (annual, 2025-10-31) — Current Liabilities: 336018.00
CNXU cash_flow (annual, 2025-10-31) — Depreciation: 7431.00
CNXU cash_flow (annual, 2025-10-31) — Depreciation Amortization Depletion: 17250.00
CNXU income_statement (annual, 2025-10-31) — Depreciation Amortization Depletion Income Statement: 17250.00
CNXU cash_flow (annual, 2025-10-31) — Depreciation And Amortization: 17250.00
CNXU income_statement (annual, 2025-10-31) — Depreciation And Amortization In Income Statement: 17250.00
CNXU income_statement (annual, 2025-10-31) — Depreciation Income Statement: 7431.00
CNXU income_statement (annual, 2025-10-31) — Diluted Average Shares: 20916173.00
CNXU income_statement (annual, 2025-10-31) — Diluted EPS: -0.19
CNXU income_statement (annual, 2025-10-31) — Diluted NI Availto Com Stockholders: -3923557.00
CNXU balance_sheet (annual, 2025-10-31) — Dueto Related Parties Current: 3722.00
CNXU income_statement (annual, 2025-10-31) — EBIT: -3918608.00
CNXU income_statement (annual, 2025-10-31) — EBITDA: -3901358.00
CNXU cash_flow (annual, 2025-10-31) — Effect Of Exchange Rate Changes: -3911.00
CNXU cash_flow (annual, 2025-10-31) — End Cash Position: 4834120.00
CNXU cash_flow (annual, 2025-10-31) — Financing Cash Flow: 6283384.00
CNXU cash_flow (annual, 2025-10-31) — Free Cash Flow: -1688643.00
CNXU income_statement (annual, 2025-10-31) — Gain On Sale Of Security: -1069.00
CNXU income_statement (annual, 2025-10-31) — General And Administrative Expense: 3398958.00
CNXU balance_sheet (annual, 2025-10-31) — Goodwill And Other Intangible Assets: 176884.00
CNXU balance_sheet (annual, 2025-10-31) — Gross PPE: 18668.00
CNXU cash_flow (annual, 2025-10-31) — Income Tax Paid Supplemental Data: 0.00
CNXU income_statement (annual, 2025-10-31) — Insurance And Claims: 8296.00
CNXU income_statement (annual, 2025-10-31) — Interest Expense: 4949.00
CNXU income_statement (annual, 2025-10-31) — Interest Expense Non Operating: 4949.00
CNXU income_statement (annual, 2025-10-31) — Interest Income: 1731.00
CNXU income_statement (annual, 2025-10-31) — Interest Income Non Operating: 1731.00
CNXU cash_flow (annual, 2025-10-31) — Interest Paid Supplemental Data: 17547.00
CNXU balance_sheet (annual, 2025-10-31) — Interest Payable: 0.00
CNXU balance_sheet (annual, 2025-10-31) — Invested Capital: 7352693.00
CNXU cash_flow (annual, 2025-10-31) — Investing Cash Flow: -89994.00
CNXU cash_flow (annual, 2025-10-31) — Issuance Of Capital Stock: 6423957.00
CNXU cash_flow (annual, 2025-10-31) — Long Term Debt Payments: -94206.00
CNXU balance_sheet (annual, 2025-10-31) — Machinery Furniture Equipment: 18668.00
CNXU cash_flow (annual, 2025-10-31) — Net Common Stock Issuance: 6423957.00
CNXU income_statement (annual, 2025-10-31) — Net Income: -3923557.00
CNXU income_statement (annual, 2025-10-31) — Net Income Common Stockholders: -3923557.00
CNXU income_statement (annual, 2025-10-31) — Net Income Continuous Operations: -3923557.00
CNXU income_statement (annual, 2025-10-31) — Net Income From Continuing And Discontinued Operation: -3923557.00
CNXU income_statement (annual, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: -3923557.00
CNXU cash_flow (annual, 2025-10-31) — Net Income From Continuing Operations: -3923557.00
CNXU income_statement (annual, 2025-10-31) — Net Income Including Noncontrolling Interests: -3923557.00
CNXU income_statement (annual, 2025-10-31) — Net Interest Income: -7335.00
CNXU cash_flow (annual, 2025-10-31) — Net Issuance Payments Of Debt: -94206.00
CNXU cash_flow (annual, 2025-10-31) — Net Long Term Debt Issuance: -94206.00
CNXU income_statement (annual, 2025-10-31) — Net Non Operating Interest Income Expense: -7335.00
CNXU cash_flow (annual, 2025-10-31) — Net Other Financing Charges: -46367.00
CNXU cash_flow (annual, 2025-10-31) — Net Other Investing Changes: -71326.00
CNXU balance_sheet (annual, 2025-10-31) — Net PPE: 11237.00
CNXU cash_flow (annual, 2025-10-31) — Net PPE Purchase And Sale: -18668.00
CNXU balance_sheet (annual, 2025-10-31) — Net Tangible Assets: 7175809.00
CNXU balance_sheet (annual, 2025-10-31) — Non Current Deferred Assets: 42177.00
CNXU income_statement (annual, 2025-10-31) — Normalized EBITDA: -3900289.00
CNXU income_statement (annual, 2025-10-31) — Normalized Income: -3922488.00
CNXU balance_sheet (annual, 2025-10-31) — Notes Receivable: 71326.00
CNXU cash_flow (annual, 2025-10-31) — Operating Cash Flow: -1669975.00
CNXU income_statement (annual, 2025-10-31) — Operating Income: -3958329.00
CNXU income_statement (annual, 2025-10-31) — Operating Revenue: 0.00
CNXU balance_sheet (annual, 2025-10-31) — Ordinary Shares Number: 20916173.00
CNXU income_statement (annual, 2025-10-31) — Other Gand A: 1119081.00
CNXU income_statement (annual, 2025-10-31) — Other Income Expense: 42107.00
CNXU balance_sheet (annual, 2025-10-31) — Other Intangible Assets: 176884.00
CNXU cash_flow (annual, 2025-10-31) — Other Non Cash Items: 794368.00
CNXU income_statement (annual, 2025-10-31) — Other Non Operating Income Expenses: 43176.00
CNXU income_statement (annual, 2025-10-31) — Other Operating Expenses: 9563.00
CNXU balance_sheet (annual, 2025-10-31) — Other Payable: 76000.00
CNXU balance_sheet (annual, 2025-10-31) — Other Receivables: 2000000.00
CNXU balance_sheet (annual, 2025-10-31) — Payables: 336018.00
CNXU balance_sheet (annual, 2025-10-31) — Payables And Accrued Expenses: 336018.00
CNXU balance_sheet (annual, 2025-10-31) — Preferred Stock: 0.00
CNXU balance_sheet (annual, 2025-10-31) — Prepaid Assets: 549930.00
CNXU income_statement (annual, 2025-10-31) — Pretax Income: -3923557.00
CNXU cash_flow (annual, 2025-10-31) — Purchase Of PPE: -18668.00
CNXU balance_sheet (annual, 2025-10-31) — Receivables: 2074363.00
CNXU income_statement (annual, 2025-10-31) — Reconciled Depreciation: 17250.00
CNXU cash_flow (annual, 2025-10-31) — Repayment Of Debt: -94206.00
CNXU income_statement (annual, 2025-10-31) — Research And Development: 478169.00
CNXU balance_sheet (annual, 2025-10-31) — Restricted Cash: 25155.00
CNXU balance_sheet (annual, 2025-10-31) — Retained Earnings: -4521520.00
CNXU income_statement (annual, 2025-10-31) — Salaries And Wages: 2271581.00
CNXU income_statement (annual, 2025-10-31) — Selling And Marketing Expense: 54389.00
CNXU income_statement (annual, 2025-10-31) — Selling General And Administration: 3453347.00
CNXU balance_sheet (annual, 2025-10-31) — Share Issued: 20916173.00
CNXU income_statement (annual, 2025-10-31) — Special Income Charges: 0.00
CNXU cash_flow (annual, 2025-10-31) — Stock Based Compensation: 1344376.00
CNXU balance_sheet (annual, 2025-10-31) — Stockholders Equity: 7352693.00
CNXU balance_sheet (annual, 2025-10-31) — Tangible Book Value: 7175809.00
CNXU income_statement (annual, 2025-10-31) — Tax Effect Of Unusual Items: 0.00
CNXU income_statement (annual, 2025-10-31) — Tax Provision: 0.00
CNXU income_statement (annual, 2025-10-31) — Tax Rate For Calcs: 0.00
CNXU balance_sheet (annual, 2025-10-31) — Taxes Receivable: 3037.00
CNXU balance_sheet (annual, 2025-10-31) — Total Assets: 7688711.00
CNXU balance_sheet (annual, 2025-10-31) — Total Capitalization: 7352693.00
CNXU balance_sheet (annual, 2025-10-31) — Total Equity Gross Minority Interest: 7352693.00
CNXU income_statement (annual, 2025-10-31) — Total Expenses: 3958329.00
CNXU balance_sheet (annual, 2025-10-31) — Total Liabilities Net Minority Interest: 336018.00
CNXU balance_sheet (annual, 2025-10-31) — Total Non Current Assets: 230298.00
CNXU balance_sheet (annual, 2025-10-31) — Total Non Current Liabilities Net Minority Interest: 0.00
CNXU income_statement (annual, 2025-10-31) — Total Operating Income As Reported: -3962446.00
CNXU income_statement (annual, 2025-10-31) — Total Other Finance Cost: 4117.00
CNXU income_statement (annual, 2025-10-31) — Total Unusual Items: -1069.00
CNXU income_statement (annual, 2025-10-31) — Total Unusual Items Excluding Goodwill: -1069.00
CNXU balance_sheet (annual, 2025-10-31) — Working Capital: 7122395.00
CNXU income_statement (quarterly, 2026-01-31) — +Operating Expense: 1720927.00
CNXU income_statement (quarterly, 2026-01-31) — +Total Revenue: 0.00
CNXU balance_sheet (quarterly, 2026-01-31) — Accounts Payable: 399297.00
CNXU balance_sheet (quarterly, 2026-01-31) — Accumulated Depreciation: -7882.00
CNXU balance_sheet (quarterly, 2026-01-31) — Additional Paid In Capital: 13046899.00
CNXU income_statement (quarterly, 2026-01-31) — Amortization: 4343.00
CNXU cash_flow (quarterly, 2026-01-31) — Amortization Cash Flow: 4343.00
CNXU cash_flow (quarterly, 2026-01-31) — Amortization Of Intangibles: 4343.00
CNXU income_statement (quarterly, 2026-01-31) — Amortization Of Intangibles Income Statement: 4343.00
CNXU income_statement (quarterly, 2026-01-31) — Basic Average Shares: 20916173.00
CNXU income_statement (quarterly, 2026-01-31) — Basic EPS: -0.08
CNXU cash_flow (quarterly, 2026-01-31) — Beginning Cash Position: 4834120.00
CNXU cash_flow (quarterly, 2026-01-31) — Capital Expenditure: -4744.00
CNXU balance_sheet (quarterly, 2026-01-31) — Capital Stock: 19846.00
CNXU balance_sheet (quarterly, 2026-01-31) — Cash And Cash Equivalents: 6255388.00
CNXU balance_sheet (quarterly, 2026-01-31) — Cash Cash Equivalents And Short Term Investments: 6255388.00
CNXU cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Financing Activities: 3416131.00
CNXU cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Investing Activities: -4744.00
CNXU cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Operating Activities: -1536356.00
CNXU cash_flow (quarterly, 2026-01-31) — Change In Account Payable: 143001.00
CNXU cash_flow (quarterly, 2026-01-31) — Change In Other Current Liabilities: 44700.00
CNXU cash_flow (quarterly, 2026-01-31) — Change In Payable: 67001.00
CNXU cash_flow (quarterly, 2026-01-31) — Change In Payables And Accrued Expense: 67001.00
CNXU cash_flow (quarterly, 2026-01-31) — Change In Prepaid Assets: -128185.00
CNXU cash_flow (quarterly, 2026-01-31) — Change In Receivables: 3037.00
CNXU cash_flow (quarterly, 2026-01-31) — Change In Working Capital: -13447.00
CNXU cash_flow (quarterly, 2026-01-31) — Changes In Cash: 1875031.00
CNXU balance_sheet (quarterly, 2026-01-31) — Common Stock: 19846.00
CNXU balance_sheet (quarterly, 2026-01-31) — Common Stock Equity: 6826402.00
CNXU cash_flow (quarterly, 2026-01-31) — Common Stock Issuance: 3005299.00
CNXU balance_sheet (quarterly, 2026-01-31) — Current Assets: 7458591.00
CNXU balance_sheet (quarterly, 2026-01-31) — Current Liabilities: 876275.00
CNXU cash_flow (quarterly, 2026-01-31) — Depreciation: 2097.00
CNXU cash_flow (quarterly, 2026-01-31) — Depreciation Amortization Depletion: 6440.00
CNXU income_statement (quarterly, 2026-01-31) — Depreciation Amortization Depletion Income Statement: 6439.00
CNXU cash_flow (quarterly, 2026-01-31) — Depreciation And Amortization: 6440.00
CNXU income_statement (quarterly, 2026-01-31) — Depreciation And Amortization In Income Statement: 6439.00
CNXU income_statement (quarterly, 2026-01-31) — Depreciation Income Statement: 2096.00
CNXU income_statement (quarterly, 2026-01-31) — Diluted Average Shares: 20916173.00
CNXU income_statement (quarterly, 2026-01-31) — Diluted EPS: -0.08
CNXU income_statement (quarterly, 2026-01-31) — Diluted NI Availto Com Stockholders: -1718823.00
CNXU balance_sheet (quarterly, 2026-01-31) — Dueto Related Parties Current: 3722.00
CNXU income_statement (quarterly, 2026-01-31) — EBIT: -1718823.00
CNXU income_statement (quarterly, 2026-01-31) — EBITDA: -1712383.00
CNXU cash_flow (quarterly, 2026-01-31) — Effect Of Exchange Rate Changes: 0.00
CNXU cash_flow (quarterly, 2026-01-31) — End Cash Position: 6709151.00
CNXU cash_flow (quarterly, 2026-01-31) — Financing Cash Flow: 3416131.00
CNXU cash_flow (quarterly, 2026-01-31) — Free Cash Flow: -1541100.00
CNXU cash_flow (quarterly, 2026-01-31) — Gain Loss On Sale Of PPE: 2741.00
CNXU income_statement (quarterly, 2026-01-31) — Gain On Sale Of Security: -7155.00
CNXU income_statement (quarterly, 2026-01-31) — General And Administrative Expense: 1534747.00
CNXU balance_sheet (quarterly, 2026-01-31) — Goodwill And Other Intangible Assets: 172541.00
CNXU balance_sheet (quarterly, 2026-01-31) — Gross PPE: 19026.00
CNXU cash_flow (quarterly, 2026-01-31) — Income Tax Paid Supplemental Data: 0.00
CNXU income_statement (quarterly, 2026-01-31) — Insurance And Claims: 4252.00
CNXU income_statement (quarterly, 2026-01-31) — Interest Expense: 0.00